Chemoimmunotherapy Efficacy in Patients with and without Liver Metastases: A Systematic Review and Meta-Analysis.
Identifying that liver metastases affect immunotherapy response helps oncologists better predict treatment success and refine patient selection strategies.
This systematic review and meta-analysis quantifies the differential efficacy of chemoimmunotherapy in patients with versus without liver metastases, addressing a clinically important biomarker for immune checkpoint therapy response. The findings could inform patient selection and treatment sequencing decisions.
What the study was
- Study design
- Systematic review and meta-analysis
- Population
- Cancer patients receiving chemoimmunotherapy with and without liver metastases
- Category
- Treatment Innovation
- Maturity
- Validated
- Journal
- Critical Reviews in Oncology/Hematology
Why it surfaced
Meta-analysis addressing a clinically meaningful immunotherapy stratification question; practical implications for treatment selection; Crit Rev Oncol Hematol appropriate venue.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.